DrugPatentWatch Database Preview

Oxaprozin - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxaprozin and what is the scope of oxaprozin patent protection?

Oxaprozin is the generic ingredient in three branded drugs marketed by Gd Searle, Actavis Elizabeth, Amneal Pharms Co, Apotex Inc, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for oxaprozin. Nineteen suppliers are listed for this compound.

Summary for oxaprozin

US Patents:	0
Tradenames:	3
Applicants:	12
NDAs:	15
Drug Master File Entries:	13
Suppliers / Packagers:	19
Bulk Api Vendors:	78
Clinical Trials:	4
Patent Applications:	6,879
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for oxaprozin
DailyMed Link:	oxaprozin at DailyMed

Pharmacology for oxaprozin

Ingredient-type	Nonsteroidal Anti-inflammatory Compounds
Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

Synonyms for oxaprozin

.beta.-(4,5-Diphenyloxazol-2-yl)propionic acid

2-Oxazolepropanoic acid, 4,5-diphenyl-

2-Oxazolepropanoic acid,5-diphenyl-

2-OXAZOLEPROPIONIC ACID, 4,5-DIPHENYL-

2-Oxazolepropionic acid,5-diphenyl-

21256-18-8

256O188

3-(4, 5-Diphenyl-2-oxazo

3-(4, 5-Diphenyl-2-oxazolyl)propenoic acid

3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid

3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid #

3-(4,5-Diphenyl-2-oxazolyl)propanoic acid

3-(4,5-Diphenyl-2-oxazolyl)propenoic acid

3-(4,5-Diphenyl-2-oxazolyl)propionic acid

3-(4,5-Diphenyl-oxazol-2-yl)-propionic acid

3-(4,5-Diphenyloxazol-2-yl)propanoic acid

3-(diphenyl-1,3-oxazol-2-yl)propanoic acid

4, 5-Diphenyl-2-oxazolepropionic acid

4,5-Diphenyl-2-oxazolepropanoic acid

4,5-Diphenyl-2-oxazolepropionic acid

4,5-diphenyloxazole-2-propanoic acid

4.5-Diphenyl-2-oxazolepropanoic acid|||Daypro

A815225

AB0011812

AB00514024

AB00514024_08

AB00514024_09

AC-26512

AC1L1IK7

AC1Q759J

AC1Q759K

Actirin

AJ-08102

AK-84489

AKOS000206807

Alvo

ANW-63377

Apo-Oxaprozin

Apotex brand of oxaprozin

B1804

BDBM50002861

beta-(4,5-Diphenyloxazol-2-yl)propionic acid

BIDD:GT0438

BIDD:PXR0149

BPBio1_001122

BRD-K25394294-001-05-7

BRN 1083168

BSPBio_001020

BSPBio_002696

C07356

C18H15NO3

CAS-21256-18-8

CCG-36508

CHEBI:7822

CHEMBL1071

CPD000058286

CS-7975

CSC brand of oxaprozin

CTK7J3117

D00463

D0M9DC

Danoprox

Daypro

Daypro (TN)

Dayrun

DB00991

Deflam

DSSTox_CID_25118

DSSTox_GSID_45118

DSSTox_RID_80684

DTXSID1045118

Durapro

Duraprost

Duraprox (TN)

EINECS 244-296-1

EN300-25629

EU-0100944

FT-0638104

GTPL7252

HE004392

HE274938

HMS1571C22

HMS1922P17

HMS2051L15

HMS2093O08

HMS2098C22

HMS3262N10

HMS3393L15

HMS3652H17

HMS566H22

HSDB 7586

HY-B0808

I14-8703

J-013955

J10396

K-6109

KB-59357

KBio3_001916

KBioGR_001722

KS-00000ULR

KS-5196

Lopac-O-9637

Lopac0_000944

LP00944

LS-100216

lyl)propenoic acid

Maybridge1_008800

MCULE-7099031811

MFCD00215977

MHJ80W9LRB

MLS000759535

MLS001424072

MolPort-000-146-829

NC00214

NCGC00014711

NCGC00014711-01

NCGC00014711-02

NCGC00014711-03

NCGC00014711-04

NCGC00014711-05

NCGC00014711-06

NCGC00014711-07

NCGC00014711-08

NCGC00014711-09

NCGC00014711-10

NCGC00014711-11

NCGC00014711-14

NCGC00094249-01

NCGC00094249-02

NCGC00094249-03

NCGC00094249-04

NCGC00094249-05

NCGC00094249-06

NCGC00094249-07

NCGC00261629-01

NCI310839

NCI60_002681

NCIStruc1_000799

NCIStruc2_000787

NSC 310839

NSC-310839

NSC-758949

NSC310839

NSC758949

O 9637

O0377

OFPXSFXSNFPTHF-UHFFFAOYSA-N

Oprea1_509470

Oxapro

oxaprosin

Oxaprozi

Oxaprozin (JP15/USAN/INN)

Oxaprozin (JP17/USAN/INN)

Oxaprozin [USAN:BAN:INN:JAN]

Oxaprozin, solid

Oxaprozin, United States Pharmacopeia (USP) Reference Standard

Oxaprozina

Oxaprozina [INN-Spanish]

Oxaprozine

Oxaprozine [INN-French]

Oxaprozinum

Oxaprozinum [INN-Latin]

Pfizer brand of oxaprozin

Pharmakon1600-01505267

Prestwick0_001060

Prestwick1_001060

Prestwick2_001060

Prestwick3_001060

Rhoxal-oxaprozin

Rhoxalpharma brand of oxaprozin

s4230

SAM001246770

SBB053166

SBI-0050918.P002

SC-13926

SCHEMBL3286

SMR000058286

SPBio_001652

SPBio_002940

SPECTRUM1505267

Spectrum2_001696

Spectrum3_001078

Spectrum4_001231

SR-01000076053-3

ST50949623

TC-152122

Tox21_110059

Tox21_110059_1

Tox21_500944

TRB brand of oxaprozin

UNII-MHJ80W9LRB

Voir

Walix

WY 21743

WY-21,743

WY-21743

Xopane

Z217102860

ZINC49643479

US Patents and Regulatory Information for oxaprozin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex Inc	OXAPROZIN	oxaprozin	TABLET;ORAL	075987-001	Sep 2, 2004	AB	RX	No	No
Actavis Elizabeth	OXAPROZIN	oxaprozin	TABLET;ORAL	075843-001	Oct 3, 2001		DISCN	No	No
Ivax Sub Teva Pharms	OXAPROZIN	oxaprozin	TABLET;ORAL	075846-001	May 13, 2002	AB	RX	No	No
Mylan	OXAPROZIN	oxaprozin	TABLET;ORAL	075851-001	Aug 17, 2001		DISCN	No	No
Watson Labs	OXAPROZIN	oxaprozin	TABLET;ORAL	075848-001	Feb 9, 2001		DISCN	No	No